CIK 0001815776
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
LENZ Therapeutics, Inc.
Sign in to watch- Ticker
- LENZ
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 844867570
- Phone
- +1 858-925-7000
- Business address
- 201 LOMAS SANTA FE DRIVE, SUITE 300, SOLANA BEACH, CA, 92075
- Former names
- Graphite Bio, Inc.
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy 10% owner bought 424,464 shares at an average $4.08 ($1,731,068)
- 4 Open-market buy CHIEF BUSINESS OFFICER bought 5,000 shares at $4.01 ($20,050)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy 10% owner bought 123,000 shares at an average $8.94 ($1,099,100)
- 4 Open-market buy 10% owner bought 97,670 shares at an average $9.10 ($888,677)
- 4 Open-market buy 10% owner bought 22,329 shares at $10.19 ($227,533)
Page 5 of 7 · 129 filings